Rox Anderson, MD
Professor of Dermatology | Vielight
Boston , MA, UNITED STATES
Dr. Richard Anderson is a dermatologist in Boston, Massachusetts and is affiliated with Massachusetts General Hospital.
Media
Publications:
Documents:
Photos:
Videos:
Audio/Podcasts:
Biography
R. Rox Anderson, is an interdisciplinary researcher in photomedicine, the combination of the physics of light with medicine. Anderson is the director of the Wellman Center for Photomedicine at Massachusetts General Hospital in Boston, MA, and faculty at the Harvard Medical School in the department of Dermatology. His contributions include laser hair removal, photodynamic therapy (use of light-activated localized drugs for cancer and macular degeneration), and basic research into the free electron laser for the selective destruction of lipids (i.e. fats) for possible treatment of acne, cellulite, and atherosclerosis, as well as various uses of photothermolysis using pulsed dye lasers.
Industry Expertise (2)
Research
Medical/Dental Practice
Areas of Expertise (8)
Photomedicine
Laser Hair Removal
Photodynamic Therapy
Free Electron Laser Therapy
Photothermosis
Human Skin Photobiology
Tissue Optics
Laser-Tissue Interactions
Education (1)
Harvard University: M.D.
Media Appearances (3)
Fat eliminating CoolSculpting now being offered at Physician Skincare Centre
Digital Journal
2016-10-11
CoolSculpting is based on the science of Cryolipolysis®, which demonstrates that when fat cells are exposed to extreme cold, the cells are crystallized, processed and then flushed out naturally by the body. R. Rox Anderson and Dieter Manstein of Harvard University made the discovery during a study that observed some children who ate popsicles experienced temporary dimples in their cheeks. The CoolSculpting procedure is more targeted, however, and diminishes fat in only specific problem areas such as the chin, thighs, arms, abdominals and back...
New ‘second skin’ could zap wrinkles, ease eczema
Science
2016-05-09
For people dealing with eczema and psoriasis, rashes and dry skin can be so severe that they can’t sleep at night, says R. Rox Anderson, an MGH dermatologist who also worked on the current study. According to Anderson about 20% of children and 10% of adults in the United States suffer from eczema.
Medical Team Gets Closer to Establish Laser Center in Armenia
Asbarez
2016-03-24
In April of 2014, a team of three dermatology laser specialists from the United States (US) returned to Yerevan, Armenia to further the development of a state of the art laser dermatology center for treatment of scars and vascular anomalies. The team of US physicians consisted of Dr. Rox Anderson of Massachusetts General Hospital and Harvard Medical School, Dr. Lilit Garibyan of Massachusetts General Hospital and Harvard Medical School, Dr. Nishan Goudsouzian of Massachusetts General Hospital and Harvard Medical School and Dr. H. Ray Jalian of UCLA Medical Center, and Dr. Christine Avakoff of Private Practice.
Event Appearances (1)
Transforming Lives with Pulses of Light
TEDxBoston 2011 Boston, MA.
Articles (5)
Reconstitution of full-thickness skin by microcolumn grafting: Reconstitution of full-thickness skin by microcolumn grafting
Journal of Tissue Engineering and Regenerative Medicine
2016 In addition to providing a physical barrier, skin also serves a diverse range of physiological functions through different specialized resident cell types/structures, including melanocytes (pigmentation and protection against ultraviolet radiation), Langerhans cells (adaptive immunity), fibroblasts (maintaining extracellular matrix, paracrine regulation of keratinocytes), sweat glands (thermoregulation) and hair follicles (hair growth, sensation and a stem cell reservoir). Restoration of these functional elements has been a long-standing challenge in efforts to engineer skin tissue, while autologous skin grafting is limited by the scarcity of donor site skin and morbidity caused by skin harvesting.
Immediate skin responses to laser and light treatments
Journal of the American Academy of Dermatology
2016 Lasers are versatile, commonly used treatment tools in dermatology. While it is tempting to follow manufacturer's guidelines or other "recipes'' for laser treatment, this approach alone can be a recipe for disaster. Specific and immediate skin responses or endpoints exist and are clinically useful because they correlate with underlying mechanisms that are either desirable (ie, therapeutic), undesirable (ie, warning signs of injury or side effects), or incidental. The observation of clinical endpoints is a safe and reliable guide for appropriate treatment. This article presents the warning endpoints during specific dermatologic laser treatments, and the accompanying article presents the therapeutic endpoints, their underlying mechanisms, and the utility of these endpoints.
All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease
Virulence
2011 The story of prevention and control of infectious diseases remains open and a series of highly virulent pathogens are emerging both in and beyond the hospital setting. Antibiotics were an absolute success story for a previous era. The academic and industrial biomedical communities have now come together to formulate consensus beliefs regarding the pursuit of novel and effective alternative anti-infective countermeasures. Photodynamic therapy was established and remains a successful modality for malignancies but photodynamic inactivation has been transformed recently to an antimicrobial discovery and development platform. The concept of photodynamic inactivation is quite straightforward and requires microbial exposure to visible light energy, typically wavelengths in the visible region, that causes the excitation of photosensitizer molecules (either exogenous or endogenous), which results in the production of singlet oxygen and other reactive oxygen species that react with intracellular components, and consequently produce cell inactivation. It is an area of increasing interest, as research is advancing i) to identify the photochemical and photophysical mechanisms involved in inactivation; ii) to develop potent and clinically compatible photosensitizer; iii) to understand how photoinactivation is affected by key microbial phenotypic elements (multidrug resistance and efflux, virulence and pathogenesis determinants, biofilms); iv) to explore novel delivery platforms inspired by current trends in pharmacology and nanotechnology; and v) to identify photoinactivation applications beyond the clinical setting such as environmental disinfectants.
Endovenous laser ablation: mechanism of action
Phlebology
2008 The objective of this study is to review the basics of laser and established tissue response patterns to thermal injury, with specific reference to endovenous laser ablation (EVLA). This study also reviews the current theories and supporting aspects for the mechanism of action of EVLA in the treatment of superficial venous reflux.
Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia
Annals of Otology, Rhinology & Laryngology
2006 Treatment of glottal papillomatosis and dysplasia was mirror-guided and done in surgeons' offices in the 19th century. It migrated to the operating room in the 20th century to accommodate direct laryngoscopic surgery, which required assistants to administer ...
Social